Cargando…
COVID-19 vaccination in pregnant women in Sweden and Norway
Vaccines against SARS-CoV-2 are highly effective in preventing severe disease and mortality. Although pregnant women are at increased risk of severe COVID-19, vaccination uptake among pregnant women varies. We used the Swedish and Norwegian population-based health registries to identify pregnant wom...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273610/ https://www.ncbi.nlm.nih.gov/pubmed/35842337 http://dx.doi.org/10.1016/j.vaccine.2022.06.083 |
_version_ | 1784745113302335488 |
---|---|
author | Örtqvist, Anne K. Dahlqwist, Elisabeth Magnus, Maria C. Ljung, Rickard Jonsson, Jerker Aronsson, Bernice Pasternak, Björn Håberg, Siri E. Stephansson, Olof |
author_facet | Örtqvist, Anne K. Dahlqwist, Elisabeth Magnus, Maria C. Ljung, Rickard Jonsson, Jerker Aronsson, Bernice Pasternak, Björn Håberg, Siri E. Stephansson, Olof |
author_sort | Örtqvist, Anne K. |
collection | PubMed |
description | Vaccines against SARS-CoV-2 are highly effective in preventing severe disease and mortality. Although pregnant women are at increased risk of severe COVID-19, vaccination uptake among pregnant women varies. We used the Swedish and Norwegian population-based health registries to identify pregnant women and to investigate background characteristics associated with not being vaccinated. In this study of 164 560 women giving birth between May 2021 and May 2022, 78% in Sweden and 87% in Norway have been vaccinated with at least one dose at delivery. Not being vaccinated while being pregnant was associated with age below 30 years, low education and income level, birth region other than Scandinavia, smoking during pregnancy, not living with a partner, and gestational diabetes. These results can assist health authorities develop targeted vaccination information to diminish vaccination inequality and prevent severe disease in vulnerable groups. |
format | Online Article Text |
id | pubmed-9273610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92736102022-07-12 COVID-19 vaccination in pregnant women in Sweden and Norway Örtqvist, Anne K. Dahlqwist, Elisabeth Magnus, Maria C. Ljung, Rickard Jonsson, Jerker Aronsson, Bernice Pasternak, Björn Håberg, Siri E. Stephansson, Olof Vaccine Short Communication Vaccines against SARS-CoV-2 are highly effective in preventing severe disease and mortality. Although pregnant women are at increased risk of severe COVID-19, vaccination uptake among pregnant women varies. We used the Swedish and Norwegian population-based health registries to identify pregnant women and to investigate background characteristics associated with not being vaccinated. In this study of 164 560 women giving birth between May 2021 and May 2022, 78% in Sweden and 87% in Norway have been vaccinated with at least one dose at delivery. Not being vaccinated while being pregnant was associated with age below 30 years, low education and income level, birth region other than Scandinavia, smoking during pregnancy, not living with a partner, and gestational diabetes. These results can assist health authorities develop targeted vaccination information to diminish vaccination inequality and prevent severe disease in vulnerable groups. The Authors. Published by Elsevier Ltd. 2022-08-05 2022-07-12 /pmc/articles/PMC9273610/ /pubmed/35842337 http://dx.doi.org/10.1016/j.vaccine.2022.06.083 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Örtqvist, Anne K. Dahlqwist, Elisabeth Magnus, Maria C. Ljung, Rickard Jonsson, Jerker Aronsson, Bernice Pasternak, Björn Håberg, Siri E. Stephansson, Olof COVID-19 vaccination in pregnant women in Sweden and Norway |
title | COVID-19 vaccination in pregnant women in Sweden and Norway |
title_full | COVID-19 vaccination in pregnant women in Sweden and Norway |
title_fullStr | COVID-19 vaccination in pregnant women in Sweden and Norway |
title_full_unstemmed | COVID-19 vaccination in pregnant women in Sweden and Norway |
title_short | COVID-19 vaccination in pregnant women in Sweden and Norway |
title_sort | covid-19 vaccination in pregnant women in sweden and norway |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273610/ https://www.ncbi.nlm.nih.gov/pubmed/35842337 http://dx.doi.org/10.1016/j.vaccine.2022.06.083 |
work_keys_str_mv | AT ortqvistannek covid19vaccinationinpregnantwomeninswedenandnorway AT dahlqwistelisabeth covid19vaccinationinpregnantwomeninswedenandnorway AT magnusmariac covid19vaccinationinpregnantwomeninswedenandnorway AT ljungrickard covid19vaccinationinpregnantwomeninswedenandnorway AT jonssonjerker covid19vaccinationinpregnantwomeninswedenandnorway AT aronssonbernice covid19vaccinationinpregnantwomeninswedenandnorway AT pasternakbjorn covid19vaccinationinpregnantwomeninswedenandnorway AT habergsirie covid19vaccinationinpregnantwomeninswedenandnorway AT stephanssonolof covid19vaccinationinpregnantwomeninswedenandnorway |